Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2016-01-13
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Ethicare GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT02654678
- Locations
- 🇳🇱
Sophia Children's Hospital Erasmus MC, Rotterdam, Netherlands
🇳🇱Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands
🇭🇺Hungarian Paediatric Heart Centre,Göttsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary
Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Ethicare GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT02652728
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
🇭🇺Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary
🇳🇱Sophia Children's Hospital, Erasmus MC, Rotterdam, Netherlands
Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Ethicare GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT02652741
- Locations
- 🇭🇺
Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary
🇷🇸Univerzitetska Dečja Klinika, Belgrade, Serbia
🇦🇹Medical University of Vienna, Vienna, Austria
Relative Bioavailability Study With Enalapril in Healthy Volunteers
- First Posted Date
- 2014-09-30
- Last Posted Date
- 2014-09-30
- Lead Sponsor
- Ethicare GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT02252692
- Locations
- 🇧🇪
Center for Clinical Pharmacology, UZ Leuven, Leuven, Belgium
© Copyright 2024. All Rights Reserved by MedPath